Sparing group | Control group | P value | |
---|---|---|---|
Number | 16 | 32 | – |
Age, year | 54.81 ± 6.585 | 54.44 ± 5.46 | 0.835 |
BMI, kg/m2 | 23.94 ± 3.64 | 24.25 ± 3.60 | 0.779 |
Smoking | |||
Present | 5 (31.25%) | 9 (28.13%) | 1.000 |
Absent | 11 (68.75%) | 23 (71.87%) | |
ASA score | |||
1 | 12 (75%) | 23 (71.88%) | 0.762 |
2 | 4 (25%) | 8 (25%) | |
3 | 0 | 1 (3.12%) | |
Tumor stage | |||
T1 | 6 (37.5%) | 11 (34.38%) | 0.946 |
T2 | 8 (50%) | 16 (50%) | |
T3 | 2 (12.5%) | 5 (15.62%) | |
Lymph node | |||
N1 | 6 (37.5%) | 13 (75%) | 0.869 |
N2 | 9 (56.25%) | 17 (75%) | |
N3 | 1 (6.25%) | 2 (75%) | |
Pelvic lymph node dissections | |||
Absent | 15 (93.75%) | 30 (93.75%) | 1.000 |
Present | 1 (6.25%) | 2 (6.25%) |